亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

High-Resolution CT Patterns of Anti-PD1 Checkpoint Inhibitor-Related Pneumonitis in Patients With Lung Cancer

医学 肺癌 过敏性肺炎 肺炎 放射科 肺炎 机化性肺炎 间质性肺病 高分辨率计算机断层扫描 癌症 隐源性机化性肺炎 病理 内科学
作者
Xiaohuan Pan,Xiaohong Xie,Xiaojuan Chen,Huai Chen
出处
期刊:Journal of Computer Assisted Tomography [Lippincott Williams & Wilkins]
卷期号:48 (6): 930-935 被引量:2
标识
DOI:10.1097/rct.0000000000001643
摘要

BACKGROUND: Lung cancer has the highest morbidity and mortality in the world, and immunotherapies have been developed for this disease in recent years. However, activation of the immune system can cause immune-related adverse events (irAEs), and checkpoint inhibitor-related pneumonitis (CIP), can be the most severe and fatal. But few reports have systematically examined the spectrum of imaging findings of this condition. Therefore, the objective of this paper is to investigate the high-resolution computed tomography (HRCT) characteristics of CIP in patients with lung cancer. OBJECTIVE: To investigate the HRCT characteristics of CIP in patients with lung cancer. METHODS: HRCT patterns in 41 lung cancer patients who developed CIP after treatment with immune checkpoint inhibitors were retrospectively characterized by interstitial lung disease classification, and their severity was graded. Specific HRCT characteristics related to CIP were identified. RESULTS: There are 4 types of immunotherapy-induce pneumonitis patterns (organizing pneumonia OP 19 cases, nonspecific interstitial pneumonia NSIP 8 cases, acute interstitial pneumonia AIP 7 cases, 7 cases of undetermined type) and image grade (13 cases of grade 1, 17 cases of grade 2, 11 cases of grade 3, 0 cases of grade 4) were identified. Spatial distribution characteristics of these lesions were noted (17 cases predominantly distributed in tumor-containing lobes, 6 cases predominantly distributed in non-tumor-containing lobes, and no specific predilection in 18 cases). Specific CT imaging features found in CIP included, in the order of prevalence, the following: ground glass opacities (38 cases), subpleural/vertical line (37 cases), interstitial thickening around the bronchovascular bundles (36 cases), reticulation (34 cases), fine reticular shadow (31 cases), consolidation (31 cases), small cystic shadow (24 cases, may not having honeycombing), small nodules (17 cases), bronchiectasis (15 cases), honeycombing (11 cases), mosaic sign (11 cases), and pleural effusion (18 cases). CONCLUSION: HRCT of CIP predominantly manifests as ground glass opacities, reticulation, subpleural/vertical line, interstitial thickening around the bronchovascular bundle, and consolidation.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
2秒前
今天完成签到,获得积分10
5秒前
yaooo发布了新的文献求助10
5秒前
keyandaren发布了新的文献求助10
6秒前
Omni发布了新的文献求助10
7秒前
田様应助沧海云帆采纳,获得10
10秒前
LB完成签到 ,获得积分10
10秒前
12秒前
haizibo完成签到,获得积分10
15秒前
青梅煮酒完成签到,获得积分10
17秒前
18秒前
认真的纸飞机完成签到 ,获得积分10
20秒前
Nole应助yaooo采纳,获得10
21秒前
21秒前
小蘑菇应助小乐采纳,获得10
26秒前
Yy发布了新的文献求助10
26秒前
Copyright应助AAZI采纳,获得10
28秒前
29秒前
Hajimimimi发布了新的文献求助10
30秒前
风中的迎丝完成签到,获得积分10
30秒前
大个应助怕黑的飞柏采纳,获得10
32秒前
wsm完成签到 ,获得积分10
33秒前
35秒前
36秒前
rerorero18发布了新的文献求助20
41秒前
沧海云帆发布了新的文献求助10
41秒前
霸气豆芽完成签到 ,获得积分10
48秒前
55秒前
研友_VZG7GZ应助颜庸采纳,获得10
57秒前
memory完成签到,获得积分10
58秒前
wop111完成签到,获得积分0
59秒前
优秀的邪欢完成签到 ,获得积分10
1分钟前
顾矜应助Debra采纳,获得10
1分钟前
1分钟前
1分钟前
小乐发布了新的文献求助10
1分钟前
科研通AI6.4应助好好好采纳,获得10
1分钟前
Kao应助科研通管家采纳,获得10
1分钟前
充电宝应助科研通管家采纳,获得10
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
《上海印钞厂志》 3000
2026年中国辛酸癸酸聚乙二醇甘油酯行业市场现状调查及投资机会研判报告 1000
2026年中国辛酸癸酸聚乙二醇甘油酯行业市场规模及竞争格局分析报告 1000
模型平均及其应用 900
Fundamentals of Pharmaceutical and Biologics Regulations: A Global Perspective, Second Edition 700
作者名:Kristopher P. Plain,悉尼大学的,目前只能查到其四篇论文,想找到其博士论文 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7338172
求助须知:如何正确求助?哪些是违规求助? 8951695
关于积分的说明 18998199
捐赠科研通 6990908
什么是DOI,文献DOI怎么找? 3218320
关于科研通互助平台的介绍 2384077
邀请新用户注册赠送积分活动 2198254